» Articles » PMID: 36187736

A Prospective Study to Evaluate the Gender Prediction of Blastocysts by Using Cell-free DNA Within a Culture Medium

Overview
Date 2022 Oct 3
PMID 36187736
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Preimplantation genetic diagnosis (PGD) has been used as an option for couples with the possibility of having a baby with a genetic disorder. The common method for performing this test involves isolating 1 cell from day 3 or a few cells from day 5 embryos and performing genetic studies on the cell-extracted DNA. This method is invasive and can cause abortion after implantation in the uterus. Because of this, 2 noninvasive methods for performing a PGD have been studied: PGD using blastocyst fluid and PGD using embryo culture medium.

Objective: The aim of this study is to determine the sensitivity of the polymerase chain reaction (PCR) technique to detect the Y chromosome using cell-free DNA within a culture medium for gender prediction of blastocysts.

Materials And Methods: In this study, the gender of 30 embryos on day 5 was determined using embryonic DNA extraction from the culture medium and the PCR technique to evaluate the sex-determining region Y and fragile X mental retardation genes. Then, the accuracy was assessed using ultrasound.

Results: The results of the PCR technique showed that 7 embryos were male, but an ultrasound revealed that 13 were male.

Conclusion: The given results indicated that, because of the low amount of DNA extracted from the culture medium, the diagnosis of the existence of the Y chromosome by this method is still not accurate enough for detecting the gender of the embryo.

References
1.
Galluzzi L, Palini S, De Stefani S, Andreoni F, Primiterra M, Diotallevi A . Extracellular embryo genomic DNA and its potential for genotyping applications. Future Sci OA. 2016; 1(4):FSO62. PMC: 5137924. DOI: 10.4155/fso.15.62. View

2.
Handyside A, Kontogianni E, Hardy K, Winston R . Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990; 344(6268):768-70. DOI: 10.1038/344768a0. View

3.
Li P, Song Z, Yao Y, Huang T, Mao R, Huang J . Preimplantation Genetic Screening with Spent Culture Medium/Blastocoel Fluid for in Vitro Fertilization. Sci Rep. 2018; 8(1):9275. PMC: 6006313. DOI: 10.1038/s41598-018-27367-4. View

4.
Tasca R, McClure M . The emerging technology and application of preimplantation genetic diagnosis. J Law Med Ethics. 2000; 26(1):7-16, 3. DOI: 10.1111/j.1748-720x.1998.tb01901.x. View

5.
Rajan-Babu I, Lian M, Cheah F, Chen M, Tan A, Prasath E . FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome. Expert Rev Mol Med. 2017; 19:e10. PMC: 5733830. DOI: 10.1017/erm.2017.10. View